US 9907803
Methods for treating attention deficit hyperactivity disorder
granted A61KA61K31/495A61K31/496
Quick answer
US patent 9907803 (Methods for treating attention deficit hyperactivity disorder) held by REVIVA PHARMACEUTICALS, INC. expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/495, A61K31/496, A61K31/535, A61K31/5355